Global Subcutaneously Injected PD-L1 Antibody Market Growth (Status and Outlook) 2026-2032

June 2026 | 70 pages | ID: GDB745584527EN
LP Information

Abstracts

The global Subcutaneously Injected PD-L1 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

PD-L1 antibody is a type of drug in tumor immunotherapy, which reduces immune suppression by binding to PD-L1 and blocking the binding between PD-1 and PD-L1, allowing T cells to exert anticancer effects. At present, PD-L1 antibodies on the market are generally administered intravenously, while subcutaneous injection can avoid various adverse reactions of intravenous infusion and improve patients' medical experience and quality of life.

This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneously Injected PD-L1 Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Add Hyaluronidase
• No Hyaluronidase

Segmentation by Application:

• Rectal and Renal Cancer
• Lung Cancer
• Other

This report also splits the market by region:

• United States
• China%li%
• Europe
• Other regions
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Roche
• Alphamab Oncology
• Bristol Myers Squibb

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Subcutaneously Injected PD-L1 Antibody Market Size (2021-2032)
  2.1.2 Subcutaneously Injected PD-L1 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Subcutaneously Injected PD-L1 Antibody by Country/Region (2021, 2025 & 2032)
2.2 Subcutaneously Injected PD-L1 Antibody Segment by Type
  2.2.1 Add Hyaluronidase
  2.2.2 No Hyaluronidase
  2.2.3 Subcutaneously Injected PD-L1 Antibody Market Size by Type
    2.2.3.1 Subcutaneously Injected PD-L1 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type (2021-2026)
2.3 Subcutaneously Injected PD-L1 Antibody Segment by Application
  2.3.1 Rectal and Renal Cancer
  2.3.2 Lung Cancer
  2.3.3 Other
  2.3.4 Subcutaneously Injected PD-L1 Antibody Market Size by Application
    2.3.4.1 Subcutaneously Injected PD-L1 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application (2021-2026)

3 SUBCUTANEOUSLY INJECTED PD-L1 ANTIBODY MARKET SIZE BY PLAYER

3.1 Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Player
  3.1.1 Global Subcutaneously Injected PD-L1 Antibody Revenue by Player (2021-2026)
  3.1.2 Global Subcutaneously Injected PD-L1 Antibody Revenue Market Share by Player (2021-2026)
3.2 Global Subcutaneously Injected PD-L1 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SUBCUTANEOUSLY INJECTED PD-L1 ANTIBODY BY REGION

4.1 Subcutaneously Injected PD-L1 Antibody Market Size by Region (2021-2026)
4.2 Global Subcutaneously Injected PD-L1 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas Subcutaneously Injected PD-L1 Antibody Market Size Growth (2021-2026)
4.4 APAC Subcutaneously Injected PD-L1 Antibody Market Size Growth (2021-2026)
4.5 Europe Subcutaneously Injected PD-L1 Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Subcutaneously Injected PD-L1 Antibody Market Size by Country (2021-2026)
5.2 Americas Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026)
5.3 Americas Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Subcutaneously Injected PD-L1 Antibody Market Size by Region (2021-2026)
6.2 APAC Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026)
6.3 APAC Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Subcutaneously Injected PD-L1 Antibody Market Size by Country (2021-2026)
7.2 Europe Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026)
7.3 Europe Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Subcutaneously Injected PD-L1 Antibody by Region (2021-2026)
8.2 Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SUBCUTANEOUSLY INJECTED PD-L1 ANTIBODY MARKET FORECAST

10.1 Global Subcutaneously Injected PD-L1 Antibody Forecast by Region (2027-2032)
  10.1.1 Global Subcutaneously Injected PD-L1 Antibody Forecast by Region (2027-2032)
  10.1.2 Americas Subcutaneously Injected PD-L1 Antibody Forecast
  10.1.3 APAC Subcutaneously Injected PD-L1 Antibody Forecast
  10.1.4 Europe Subcutaneously Injected PD-L1 Antibody Forecast
  10.1.5 Middle East & Africa Subcutaneously Injected PD-L1 Antibody Forecast
10.2 Americas Subcutaneously Injected PD-L1 Antibody Forecast by Country (2027-2032)
  10.2.1 United States Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.2.2 Canada Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.2.3 Mexico Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.2.4 Brazil Market Subcutaneously Injected PD-L1 Antibody Forecast
10.3 APAC Subcutaneously Injected PD-L1 Antibody Forecast by Region (2027-2032)
  10.3.1 China Subcutaneously Injected PD-L1 Antibody Market Forecast
  10.3.2 Japan Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.3.3 Korea Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.3.4 Southeast Asia Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.3.5 India Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.3.6 Australia Market Subcutaneously Injected PD-L1 Antibody Forecast
10.4 Europe Subcutaneously Injected PD-L1 Antibody Forecast by Country (2027-2032)
  10.4.1 Germany Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.4.2 France Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.4.3 UK Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.4.4 Italy Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.4.5 Russia Market Subcutaneously Injected PD-L1 Antibody Forecast
10.5 Middle East & Africa Subcutaneously Injected PD-L1 Antibody Forecast by Region (2027-2032)
  10.5.1 Egypt Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.5.2 South Africa Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.5.3 Israel Market Subcutaneously Injected PD-L1 Antibody Forecast
  10.5.4 Turkey Market Subcutaneously Injected PD-L1 Antibody Forecast
10.6 Global Subcutaneously Injected PD-L1 Antibody Forecast by Type (2027-2032)
10.7 Global Subcutaneously Injected PD-L1 Antibody Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Subcutaneously Injected PD-L1 Antibody Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Subcutaneously Injected PD-L1 Antibody Product Offered
  11.1.3 Roche Subcutaneously Injected PD-L1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Alphamab Oncology
  11.2.1 Alphamab Oncology Company Information
  11.2.2 Alphamab Oncology Subcutaneously Injected PD-L1 Antibody Product Offered
  11.2.3 Alphamab Oncology Subcutaneously Injected PD-L1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Alphamab Oncology Main Business Overview
  11.2.5 Alphamab Oncology Latest Developments
11.3 Bristol Myers Squibb
  11.3.1 Bristol Myers Squibb Company Information
  11.3.2 Bristol Myers Squibb Subcutaneously Injected PD-L1 Antibody Product Offered
  11.3.3 Bristol Myers Squibb Subcutaneously Injected PD-L1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Bristol Myers Squibb Main Business Overview
  11.3.5 Bristol Myers Squibb Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Subcutaneously Injected PD-L1 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Subcutaneously Injected PD-L1 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Add Hyaluronidase
Table 4. Major Players of No Hyaluronidase
Table 5. Subcutaneously Injected PD-L1 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type (2021-2026)
Table 8. Subcutaneously Injected PD-L1 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application (2021-2026)
Table 11. Global Subcutaneously Injected PD-L1 Antibody Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Subcutaneously Injected PD-L1 Antibody Revenue Market Share by Player (2021-2026)
Table 13. Subcutaneously Injected PD-L1 Antibody Key Players Head office and Products Offered
Table 14. Subcutaneously Injected PD-L1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Subcutaneously Injected PD-L1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Region (2021-2026)
Table 19. Global Subcutaneously Injected PD-L1 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Subcutaneously Injected PD-L1 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Subcutaneously Injected PD-L1 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Country (2021-2026)
Table 23. Americas Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type (2021-2026)
Table 25. Americas Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application (2021-2026)
Table 27. APAC Subcutaneously Injected PD-L1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Region (2021-2026)
Table 29. APAC Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Subcutaneously Injected PD-L1 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Country (2021-2026)
Table 33. Europe Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Subcutaneously Injected PD-L1 Antibody
Table 39. Key Market Challenges & Risks of Subcutaneously Injected PD-L1 Antibody
Table 40. Key Industry Trends of Subcutaneously Injected PD-L1 Antibody
Table 41. Global Subcutaneously Injected PD-L1 Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Subcutaneously Injected PD-L1 Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Subcutaneously Injected PD-L1 Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Roche Details, Company Type, Subcutaneously Injected PD-L1 Antibody Area Served and Its Competitors
Table 46. Roche Subcutaneously Injected PD-L1 Antibody Product Offered
Table 47. Roche Subcutaneously Injected PD-L1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Alphamab Oncology Details, Company Type, Subcutaneously Injected PD-L1 Antibody Area Served and Its Competitors
Table 51. Alphamab Oncology Subcutaneously Injected PD-L1 Antibody Product Offered
Table 52. Alphamab Oncology Subcutaneously Injected PD-L1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Alphamab Oncology Main Business
Table 54. Alphamab Oncology Latest Developments
Table 55. Bristol Myers Squibb Details, Company Type, Subcutaneously Injected PD-L1 Antibody Area Served and Its Competitors
Table 56. Bristol Myers Squibb Subcutaneously Injected PD-L1 Antibody Product Offered
Table 57. Bristol Myers Squibb Subcutaneously Injected PD-L1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bristol Myers Squibb Main Business
Table 59. Bristol Myers Squibb Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Subcutaneously Injected PD-L1 Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Subcutaneously Injected PD-L1 Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Subcutaneously Injected PD-L1 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Subcutaneously Injected PD-L1 Antibody Sales Market Share by Country/Region (2025)
Figure 8. Subcutaneously Injected PD-L1 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type in 2025
Figure 10. Subcutaneously Injected PD-L1 Antibody in Rectal and Renal Cancer
Figure 11. Global Subcutaneously Injected PD-L1 Antibody Market: Rectal and Renal Cancer (2021-2026) & ($ millions)
Figure 12. Subcutaneously Injected PD-L1 Antibody in Lung Cancer
Figure 13. Global Subcutaneously Injected PD-L1 Antibody Market: Lung Cancer (2021-2026) & ($ millions)
Figure 14. Subcutaneously Injected PD-L1 Antibody in Other
Figure 15. Global Subcutaneously Injected PD-L1 Antibody Market: Other (2021-2026) & ($ millions)
Figure 16. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application in 2025
Figure 17. Global Subcutaneously Injected PD-L1 Antibody Revenue Market Share by Player in 2025
Figure 18. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Region (2021-2026)
Figure 19. Americas Subcutaneously Injected PD-L1 Antibody Market Size 2021-2026 ($ millions)
Figure 20. APAC Subcutaneously Injected PD-L1 Antibody Market Size 2021-2026 ($ millions)
Figure 21. Europe Subcutaneously Injected PD-L1 Antibody Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size 2021-2026 ($ millions)
Figure 23. Americas Subcutaneously Injected PD-L1 Antibody Value Market Share by Country in 2025
Figure 24. United States Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Region in 2025
Figure 29. APAC Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type (2021-2026)
Figure 30. APAC Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application (2021-2026)
Figure 31. China Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 35. India Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Country in 2025
Figure 38. Europe Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type (2021-2026)
Figure 39. Europe Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application (2021-2026)
Figure 40. Germany Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 41. France Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Subcutaneously Injected PD-L1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 54. APAC Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 55. Europe Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 57. United States Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 58. Canada Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 59. Mexico Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 60. Brazil Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 61. China Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 62. Japan Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 63. Korea Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 65. India Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 66. Australia Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 67. Germany Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 68. France Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 69. UK Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 70. Italy Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 71. Russia Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 72. Egypt Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 73. South Africa Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 74. Israel Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 75. Turkey Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)
Figure 76. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Subcutaneously Injected PD-L1 Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Subcutaneously Injected PD-L1 Antibody Market Size 2027-2032 ($ millions)